Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA

/PRNewswire/ -- On February 19, 2024, the Journal of American Medical Association•Neurology (JAMA NEUROLOGY, IF: 29.0) published online the key findings of a...

Related Keywords

Nanjing ,Jiangsu ,China ,United States ,Dongsheng ,Jilin ,Peking ,Beijing ,American ,Wang Yongjun ,Neurodawn Pharmaceutical Co Ltd ,Simcere Pharmaceutical Group ,Tiantan Hospital Of Capital Medical University ,National Medical Products Administration Of China ,Simcere Pharmaceutical Group Ltd ,University Third Hospital ,Journal Of American Medical Association ,American Medical Association ,Dexborneol Concentrated Solution ,New Drug Application ,National Medical Products Administration ,Beijing Tiantan Hospital ,Capital Medical University ,Fan Dongsheng ,Peking University Third Hospital ,Pharmaceutical Group ,Simcere Pharmaceutical Group Limited ,Pharmaceuticals ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,